Chris Shanahan is a principal at DFJ Growth. Prior to joining the firm in 2018, Chris was an analyst at Greenhill & Co. focused on mergers and acquisitions across a range of industries, including enterprise technologies and related infrastructure. He previously worked in biomedical engineering research and development groups at Boston Scientific and Acclarent, a subsidiary of Johnson & Johnson. Chris holds a bachelor of science with honors in biomedical engineering from Cal Poly.